News-Zhengqing Group_Pharmaceutical product R&D

Blog

Seek truth from facts, competitive symbiosis

scroll down

Temporary Announcement

Home page

2022-11

United in Purpose, Together Fighting the Epidemic | Zhengqing Group Donated 1 Million Yuan Worth of Anti-Epidemic Medicines to Aid Shaoyang County

View Details

2022-11

United in fighting the epidemic | Caring donation, overcoming challenges together -- Zhengqing Group donates a batch of epidemic prevention medicines to Huaihua High-tech Zone

View Details

2022-11

Lead by example, bravely stand firm! Wu Feichi, Chairman, Party Secretary, and President of the Group Company, led employees to hold fast to ensure production.

View Details

2022-11

Uniting efforts to fight the epidemic and fulfilling social responsibilities with commitment — Hunan Zhengqing Group Donates 1 Million Yuan Worth of Anti-Epidemic Drugs

View Details

2022-10

The re-election meeting of the Zhengqing Group Party Committee was successfully convened, electing the fourth Party Committee and Disciplinary Committee leadership.

View Details

2022-10

A research team from the Center for Urban and Small Town Reform and Development, National Development and Reform Commission, investigated Zhengqing Group.

View Details

2022-09

Focusing on the hundred-billion blue ocean, Zhengqing Group debuted at the 85th Pharmaceutical Exhibition.

View Details

2022-09

Measures for Hazardous Waste Pollution Prevention and Control at the Raw Material and Preparation Plant Area in 2021

The API production plant is located at No. 3 Shidai Road, Huaihua High-tech Industrial Development Zone, covering an area of 48.2 mu. It has an annual output of 8 tons of Sinomenine Hydrochloride and serves as the active pharmaceutical ingredient for the Zhengqing Fengtongning series of products. The project passed the environmental protection acceptance upon completion in June 2019.

View Details